Christentze Schmiegelow

Christentze Schmiegelow

Auto-generated profile, based on publicly available information

Christentze Schmiegelow

Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in The Lancet
Verified
Journal Article
Closed access
JKJoanne Katz
Joanne Katz
ALAnne Cc Lee
Anne Cc Lee
NKNaoko Kozuki
Naoko Kozuki
JLJoy E Lawn
Joy E Lawn
SCSimon Cousens
Simon Cousens
RBRobert E. Black
Robert E. Black

17 August 2017 in BMJ
Verified
Journal Article
Open access
PDF file
ALAnne CC Lee
Anne CC Lee
NKNaoko Kozuki
Naoko Kozuki
SCSimon Cousens
Simon Cousens
GSGretchen A Stevens
Gretchen A Stevens
HBHannah Blencowe
Hannah Blencowe
JKJoanne Katz
Joanne Katz
Objectives To estimate small for gestational age birth prevalence and attributable neonatal mortality in low and middle income countries with the INTERGROWTH-21st birth weight standard. Design Secondary analysis of data from the Child Health Epidemiology Reference Group (CHERG), including 14 birth cohorts with gestational age, birth weight, and neonatal follow-up. Small for gestational age was defined as infants weighing less than the 10th centile birth weight for gestational age and sex with the multiethnic, INTERGROWTH-21st birth weight standard. Prevalence of small for gestational age and neonatal mortality risk ratios were calculated and pooled among these datasets at the regional level. With available national level data, prevalence of small for gestational age and population attributable fractions of neonatal mortality attributable to small for gestational age were estimated. Setting CHERG birth cohorts from 14 population based sites in low and middle income countries. Main outcome measures In low and middle income countries in the year 2012, the number and proportion of infants born small for gestational age; number and proportion of neonatal deaths attributable to small for gestational age; the number and proportion of neonatal deaths that could be prevented by reducing the prevalence of small for gestational age to 10%. Results In 2012, an estimated 23.3 million infants (uncertainty range 17.6 to 31.9; 19.3% of live births) were born small for gestational age in low and middle income countries. Among these, 11.2 million (0.8 to 15.8) were term and not low birth weight (≥2500 g), 10.7 million (7.6 to 15.0) were term and low birth weight (<2500 g) and 1.5 million (0.9 to 2.6) were preterm. In low and middle income countries, an estimated 606 500 (495 000 to 773 000) neonatal deaths were attributable to infants born small for gestational age, 21.9% of all neonatal deaths. The largest burden was in South Asia, where the prevalence was the highest (34%); about 26% of neonatal deaths were attributable to infants born small for gestational age. Reduction of the prevalence of small for gestational age from 19.3% to 10.0% in these countries could reduce neonatal deaths by 9.2% (254 600 neonatal deaths; 164 800 to 449 700). Conclusions In low and middle income countries, about one in five infants are born small for gestational age, and one in four neonatal deaths are among such infants. Increased efforts are required to improve the quality of care for and survival of these high risk infants in low and middle income countries

1 November 2015 in The Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
CGChild Health Epidemiology Reference Group Small-for-Gestational-Age/Preterm Birth Working Group
Child Health Epidemiology Reference Group Small-for-Gestational-Age/Preterm Birth Working Group
NKNaoko Kozuki
Naoko Kozuki
JKJoanne Katz
Joanne Katz
ALAnne Cc Lee
Anne Cc Lee
JVJoshua P Vogel
Joshua P Vogel
RBRobert E Black
Robert E Black
Background: Small-for-gestational-age (SGA) and preterm births are associated with adverse health consequences, including neonatal and infant mortalit

14 August 2012 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
TMTanya Marchant
Tanya Marchant
BWBarbara Willey
Barbara Willey
JKJoanne Katz
Joanne Katz
SCSiân Clarke
Siân Clarke
SKSimon Kariuki
Simon Kariuki
JSJoanna Armstrong Schellenberg
Joanna Armstrong Schellenberg
Low birth weight and prematurity are amongst the strongest predictors of neonatal death. However, the extent to which they act independently is poorly understood. Our objective was to estimate the neonatal mortality risk associated with preterm birth when stratified by weight for gestational age in the high mortality setting of East Africa. Members and collaborators of the Malaria and the MARCH Centers, at the London School of Hygiene & Tropical Medicine, were contacted and protocols reviewed for East African studies that measured (1) birth weight, (2) gestational age at birth using antenatal ultrasound or neonatal assessment, and (3) neonatal mortality. Ten datasets were identified and four met the inclusion criteria. The four datasets (from Uganda, Kenya, and two from Tanzania) contained 5,727 births recorded between 1999–2010. 4,843 births had complete outcome data and were included in an individual participant level meta-analysis. 99% of 445 low birth weight (<2,500 g) babies were either preterm (<37 weeks gestation) or small for gestational age (below tenth percentile of weight for gestational age). 52% of 87 neonatal deaths occurred in preterm or small for gestational age babies. Babies born <34 weeks gestation had the highest odds of death compared to term babies (odds ratio [OR] 58.7 [95% CI 28.4–121.4]), with little difference when stratified by weight for gestational age. Babies born 34–36 weeks gestation with appropriate weight for gestational age had just three times the likelihood of neonatal death compared to babies born term, (OR 3.2 [95% CI 1.0–10.7]), but the likelihood for babies born 34–36 weeks who were also small for gestational age was 20 times higher (OR 19.8 [95% CI 8.3–47.4]). Only 1% of babies were born moderately premature and small for gestational age, but this group suffered 8% of deaths. Individual level data on newborns are scarce in East Africa; potential biases arising due to the non-systematic selection of the individual studies, or due to the methods applied for estimating gestational age, are discussed. Moderately preterm babies who are also small for gestational age experience a considerably increased likelihood of neonatal death in East Africa. Please see later in the article for the Editors' Summary.

1 September 2013 in Emerging Infectious Diseases
Verified
Journal Article
Open access
DMDaniel Minja
Daniel Minja
CSChristentze Schmiegelow
Christentze Schmiegelow
BMBruno Mmbando
Bruno Mmbando
SBStéphanie Boström
Stéphanie Boström
MOMayke Oesterholt
Mayke Oesterholt
MAMichael Alifrangis
Michael Alifrangis
Intermittent preventive treatment during pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) is a key strategy in the control of pregnancy-associated malaria. However, this strategy is compromised by widespread drug resistance from single-nucleotide polymorphisms in the Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthetase genes. During September 2008–October 2010, we monitored a cohort of 924 pregnant women in an area of Tanzania with declining malaria transmission. P. falciparum parasites were genotyped, and the effect of infecting haplotypes on birthweight was assessed. Of the genotyped parasites, 9.3%, 46.3%, and 44.4% had quadruple or less, quintuple, and sextuple mutated haplotypes, respectively. Mutant haplotypes were unrelated to SP doses. Compared with infections with the less-mutated haplotypes, infections with the sextuple haplotype mutation were associated with lower (359 g) birthweights. Continued use of the suboptimal IPTp-SP regimen should be reevaluated, and alternative strategies (e.g., intermittent screening and treatment or intermittent treatment with safe and effective alternative drugs) should be evaluated.

7 June 2012 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
PDF file
CSChristentze Schmiegelow
Christentze Schmiegelow
DMDaniel Minja
Daniel Minja
MOMayke Oesterholt
Mayke Oesterholt
CPCaroline Pehrson
Caroline Pehrson
HSHannah Elena Suhrs
Hannah Elena Suhrs
BNBirgitte Bruun Nielsen
Birgitte Bruun Nielsen
Objective. To identify factors associated with perinatal mortality in northeastern Tanzania. Design. Prospective cohort study. Setting. Northeastern Tanzania. Population. 872 mothers and their newborns. Methods. Pregnant women were screened for factors possibly associated with perinatal mortality, including preeclampsia, small‐for‐gestational age, preterm delivery, anemia, and health‐seeking behavior. Fetal growth was monitored using ultrasound. Finally, the specific causes of the perinatal deaths were evaluated. Main outcome measure. Perinatal mortality. Results. Forty‐six deaths occurred. Key factors associated with perinatal mortality were preterm delivery (adjusted odds ratio (OR) 14.47, 95% confidence interval (CI) 3.23–64.86, p < 0.001), small‐for‐gestational age (adjusted OR 3.54, 95%CI 1.18–10.61, p = 0.02), and maternal anemia (adjusted OR 10.34, 95%CI 1.89–56.52, p = 0.007). Adherence to the antenatal care program (adjusted OR 0.027, 95%CI 0.003–0.26, p = 0.002) protected against perinatal mortality. The cause of death in 43% of cases was attributed to complications related to labor and specifically to intrapartum asphyxia (30%) and neonatal infection (13%). Among the remaining deaths, 27% (7/26) were attributed to preeclampsia and 23% (6/26) to small‐for‐gestational age. Of these, 54% (14/26) were preterm. Conclusions. Preeclampsia, small‐for‐gestational age and preterm delivery were key risk factors and causes of perinatal mortality in this area of Tanzania. Maternal anemia was also strongly associated with perinatal mortality. Furthermore, asphyxia accounted for a large proportion of the perinatal deaths. Interventions should target the prevention and handling of these conditions in order to reduce perinatal mortality.